Core Viewpoint - A lawsuit has been filed against Molina Healthcare, Inc. and its senior executives for potential violations of federal securities laws, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Group 1: Lawsuit Details - Investors have until December 2, 2025, to request to lead the case, which is pending in the U.S. District Court for the Central District of California [2]. - The lawsuit is titled Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461 [2]. Group 2: Company Background - Molina Healthcare is a health insurance company that provides managed healthcare services to low-income individuals under Medicaid and Medicare programs [3]. - The company previously claimed a "solid" earnings growth profile heading into 2025 and stated it was able to mitigate healthcare cost inflation [3]. Group 3: Financial Performance and Stock Impact - On July 7, 2025, Molina reported Q2 2025 adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [4]. - The company cut its guidance for expected adjusted earnings per share by 10.2%, revising it to a range of $21.50 to $22.50 per share [4]. - Following further revelations on July 23, 2025, regarding a challenging medical cost trend environment, Molina's stock price fell by $32.03 per share, or 16.8%, from $190.25 to $158.22 [4].

Core Viewpoint - The Molina Healthcare class action lawsuit alleges that the company and its executives failed to disclose critical information regarding financial performance and medical cost trends, leading to significant stock price declines during the class period [1][3][4]. Summary by Sections Class Action Details - The class action lawsuit is titled Hindlemann v. Molina Healthcare, Inc., and covers purchasers of Molina Healthcare securities from February 5, 2025, to July 23, 2025, with a deadline of December 2, 2025, for lead plaintiff applications [1][2]. Allegations Against Molina Healthcare - The lawsuit claims that Molina Healthcare did not disclose adverse facts about its medical cost trend assumptions, the dislocation between premium rates and medical costs, and the dependency of near-term growth on low utilization of various health services [3]. - It is alleged that Molina Healthcare's financial guidance for fiscal year 2025 was likely to be cut due to these undisclosed issues [3]. Financial Performance and Stock Impact - On July 7, 2025, Molina Healthcare reported adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines, leading to a 10.2% cut in earnings guidance [4]. - Following the financial results announcement on July 23, 2025, Molina Healthcare reported GAAP net income of $4.75 per diluted share for Q2 2025, an 8% decrease year-over-year, and revised its full-year 2025 adjusted earnings expectation to no less than $19.00 per diluted share, resulting in a nearly 17% drop in stock price [5]. Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Molina Healthcare securities during the class period to seek lead plaintiff status, which involves directing the class action lawsuit on behalf of all class members [6]. About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone, and is recognized for securing significant monetary relief for investors [7][8].

Group 1 - A securities class action lawsuit has been filed against Molina Healthcare, Inc. on behalf of investors who purchased or acquired Molina securities between February 5, 2025, and July 23, 2025 [1] - The lead plaintiff deadline for the lawsuit is set for December 2, 2025 [1]

Core Viewpoint - Investors in Molina Healthcare, Inc. have the opportunity to lead a securities fraud class action lawsuit due to undisclosed adverse facts affecting the company's financial guidance and operations [1][2]. Summary by Relevant Sections Lawsuit Details - The lawsuit alleges that from February 5, 2025, to July 23, 2025, Molina failed to disclose critical information regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [2]. - It is claimed that Molina's growth was reliant on limited utilization of various health services, which could lead to a significant reduction in the company's financial guidance for fiscal year 2025 [2]. Investor Participation - Investors who suffered losses related to Molina Healthcare are encouraged to participate in the ongoing lawsuit, with a lead plaintiff deadline set for December 2, 2025 [2]. - Interested parties can contact the Law Offices of Frank R. Cruz for more information or to participate [3][4].

Core Viewpoint - A lawsuit has been filed against Molina Healthcare, Inc. and certain senior executives for potential violations of federal securities laws, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Group 1: Lawsuit Details - Investors have until December 2, 2025, to request to lead the case, which is pending in the U.S. District Court for the Central District of California [2]. - The case is titled Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461 [2]. Group 2: Company Background - Molina Healthcare is a health insurance company providing managed healthcare services to low-income individuals under Medicaid and Medicare programs [3]. - The company previously claimed a "solid" earnings growth profile heading into 2025 and stated it was monitoring utilization patterns to mitigate healthcare cost inflation [3]. Group 3: Financial Performance and Stock Impact - On July 7, 2025, Molina reported Q2 2025 adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [4]. - The company cut its guidance for expected adjusted earnings per share by 10.2%, revising it to a range of $21.50 to $22.50 per share [4]. - On July 23, 2025, Molina adjusted its full-year 2025 earnings expectation to no less than $19.00 per diluted share, citing a challenging medical cost trend environment [4]. - Following this announcement, Molina's stock price fell by $32.03 per share, or 16.8%, from $190.25 to $158.22 [4].

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Molina Healthcare, Inc. (“Molina” or “the Company”) (NYSE: MOH) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Molina sec ...

LOS ANGELES, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 2, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR MOLINA INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO ...

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Molina business and prospects, resulting in its stock trading at inflated prices. ...

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of Molina Healthcare, Inc. securities between February 5, 2025, and July 23, 2025, due to undisclosed adverse facts affecting the company's financial guidance and operations [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Molina Healthcare failed to disclose material adverse facts regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [5]. - The lawsuit alleges that Molina's near-term growth relied on a lack of utilization of various health services, which was not communicated to investors [5]. - As a result of these undisclosed facts, Molina's financial guidance for fiscal year 2025 was likely to be cut, leading to misleading positive statements about the company's business and prospects [5]. Group 2: Participation Information - Investors who purchased Molina securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6].

Core Points - ClaimsFiler reminds investors of the deadline to file lead plaintiff applications in a securities class action lawsuit against Molina Healthcare, Inc. for the Class Period from February 5, 2025, to July 23, 2025 [1] - The lawsuit alleges that Molina Healthcare and certain executives failed to disclose material information, violating federal securities laws [3] - Following the company's second-quarter financial results announcement on July 23, 2025, which included an 8% year-over-year decrease in GAAP net income and a cut in full-year earnings guidance, Molina's share price dropped by 16.84% [4] Company Information - Molina Healthcare reported a GAAP net income of $4.75 per diluted share for Q2 2025, down from the previous year, and adjusted earnings expectations for the full year 2025 to be no less than $19.00 per diluted share due to challenging medical cost trends [4] - The case is officially titled Hindlemann v. Molina Healthcare, Inc., et al., No. 2:25-cv-09461 [5] Investor Resources - ClaimsFiler provides a platform for retail investors to recover funds from securities class action settlements, offering free registration, portfolio data uploads, and inquiries for case evaluations [6]